Obamacare: Where Do We Stand Today? By Tom Emerick David Toomey While it’s hard to dispute the benefits of insurance for everyone, we still must cut the cost of healthcare.
How to Stop Unneeded Medical Tests (Video) By Richard Anderson Erik Leander How should physicians respond to patients who request unnecessary medical tests? Here are some tips.
Transparent Reinsurance for Health By Hugh Carter Donahue Transparent reinsurance programs to address health insurance could emerge as significant opportunities.
Healthcare Quality: How to Define It By Tom Emerick David Toomey How do we move beyond the marketing campaigns to understand healthcare suppliers’ performance?
10 Reasons Why Healthcare Varies By Craig Lack What if healthcare came with a warning label? "Results vary. They can include hospital-acquired infections and premature death."
It's Time to Embrace Telemedicine By Sally Pipes Studies show that telemedicine can cut Medicare spending by 13% and conventional inpatient care by 19%...and that's just the start.
Perils of 'Defensive Medicine' (Video) By Erik Leander Richard Anderson In the first of a series, Dr. Richard Anderson explains how truly dangerous "defensive medicine" can be.
3 Things to Know on PPO Networks By Andy Neary If you are an employer looking for creative ways to give your employees great care, PPO networks may stand in the way.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.